← FDA Drug Approvals (Drugs@FDA)

SAPHNELO

BLA · Biologics License Application · Sponsor: ASTRAZENECA AB · Approved 2026-04-24

Drug application

FDA Application #

BLA761451

Application type

Biologics License Application

Brand name

SAPHNELO

Generic name

ANIFROLUMAB-FNIA

Active ingredients

ANIFROLIMAB-FNIA

Dosage form

INJECTION

Route

—

Marketing status

Prescription

Sponsor

ASTRAZENECA AB

Manufacturer

AstraZeneca Pharmaceuticals LP

First approval

2026-04-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown